Deals channel feed

Leap Ther­a­peu­tics jumps in­to grow­ing Claudin18.2 field by buy­ing Flame Bio­sciences

3 years ago
Financing
Startups

Can­cer vac­cine de­vel­op­er jumps to Nas­daq via re­verse merg­er

3 years ago

Three Ohio-based con­tract or­ga­ni­za­tions win $149M deal for neu­ro­log­i­cal can­di­dates

3 years ago
Outsourcing
Manufacturing

ICY­MI: 'What could they pos­si­bly buy?' Sanofi's Paul Hud­son talks M&A hes­i­ta­tion at #JPM23

3 years ago
Pharma

Ver­tex gets more pre­cise with Ar­bor in ex­pand­ed gene edit­ing pact

3 years ago
Startups
Cell/Gene Tx

Co­herus pays out $32M for ex­clu­sive US com­mer­cial­iza­tion rights to Eylea biosim­i­lar

3 years ago

Re­silience starts the year with its first deal out­side of North Amer­i­ca

3 years ago
Manufacturing

Ab­b­Vie signs mR­NA pact with An­i­ma Biotech for $42M up­front

3 years ago
AI

BioN­Tech buys out AI part­ner In­staDeep for $440M in bid to be­come ‘tech­nol­o­gy com­pa­ny’

3 years ago
Startups
AI

Novotech's lat­est ac­qui­si­tions grow its US pres­ence and plant a Eu­ro­pean foothold

3 years ago
Outsourcing
Manufacturing

Io­n­is sells par­tial stake in roy­al­ties from Spin­raza and No­var­tis car­dio drug to Roy­al­ty Phar­ma for $500M up­front

3 years ago

Voy­ager goes big, se­cur­ing mul­ti-bil­lion dol­lar gene ther­a­py de­vel­op­ment deal with Neu­ro­crine

3 years ago
Cell/Gene Tx

As­traZeneca bets up to $1.8B on Cin­Cor and its ex-Roche drug for hy­per­ten­sion

3 years ago
Pharma

At #JPM23, an­oth­er rare dis­ease buy­out as Ipsen ac­quires Al­bireo for $952M

3 years ago
Pharma

Kro­nos and Genen­tech ink $20M can­cer dis­cov­ery pact

3 years ago
R&D

Ex­clu­sive: Eli Lil­ly boosts in­flam­ma­to­ry dis­ease pipeline, li­cens­es three can­di­dates from TRexBio

3 years ago

No­var­tis of­floads neu­rode­vel­op­men­tal dis­or­der as­set to small Swiss biotech

3 years ago
Startups
Pharma

Qi­a­gen picks up DNA foren­sics com­pa­ny for $150M

3 years ago
Diagnostics

#JPM23 kicks off with an ac­qui­si­tion as Chiesi inks all-cash $1B+ deal for Am­ryt

3 years ago
Pharma

Emer­gent award­ed $379M+ to sup­ply the DOD with a skin de­con­t­a­m­i­na­tion lo­tion

3 years ago
Pharma
Manufacturing

Bet­ting on cell mem­o­ry, Ab­b­Vie pays Im­munome $30M up­front to fur­ther an­ti­body re­search

3 years ago

Mod­er­na piv­ots from a buy­out to a plat­form tech al­liance as its strug­gling part­ner scores an­oth­er mar­quee al­ly

3 years ago

Fate and J&J end deal that once promised $3B in mile­stones; biotech cuts staff

3 years ago
Pharma

On in vi­vo cell ther­a­py quest, Take­da-backed En­so­ma buys a CRISPR up­start and bags $85M

3 years ago
Financing
Cell/Gene Tx
First page Previous page 42434445464748 Next page Last page
A service from the Financial Times